Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
The combination creates a synergistic effect where the whole is genuinely greater than the sum of its parts
Tesamorelin has an identical 44-amino-acid structure, whereas sermorelin consists of only the first 29
Active Ingredient Semaglutide (Advanced GLP-1 Receptor Agonist) Cartridge Concentration 15 mg Semaglutide per 3ml Cartridge (5 mg/mL) Delivery Tool Semanext 1 Reusable Customized Precision Injector Pen Primary Manufacturer Lupin Ltd Administration Route Subcutaneous Injection (Weekly adjustable baseline) 1 Cartridge + 1 Reusable Pen + 10 Sterile Needles Primary Indication Chronic Anti-Obesity Management & Type 2 Diabetes Support
(2025) [123], showing that weight regain typically begins around eight weeks after discontinuation and continues through week 20, with the early posttreatment phase being especially vulnerable
Supported by Our Unmatched Guarantee: We stand behind the quality and efficacy of our product
For a direct comparison between AOD-9604 and retatrutide research profiles, see our AOD-9604 vs retatrutide article
